Crosstalk between 5-methylcytosine and N 6 -methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma.
Yu TianHaijuan XiaoYanhui YangPingping ZhangJiahui YuanWei ZhangLijie ChenYibao FanJinze ZhangHuan ChengTingwei DengLin YangWeiwei WangGuoyong ChenPeiqin WangPeng GongXing NiuXianbin ZhangPublished in: Molecular cancer (2023)
A-epitranscriptomic mechanism, and their crosstalk defines therapeutic response and pharmacogenomic landscape.
Keyphrases